Zobrazeno 1 - 10
of 1 971
pro vyhledávání: '"respiratory syncytial virus (RSV)"'
Autor:
Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho, Ataru Igarashi
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 303-311 (2024)
ABSTRACTBackground Respiratory syncytial virus (RSV), a common respiratory pathogen, can lead to severe symptoms, especially in older adults (OA). A recently developed RSV prefusion F protein (RSVPreF3 OA) vaccine confers high protection against RSV
Externí odkaz:
https://doaj.org/article/5257110ff0d74e0b89f9b9977b98216e
Autor:
Robert Buynak, Kevin Cannon, David DeAtkine, John Kirby, Lisa Usdan, Amit Bhavsar, Catherine Gérard, Anastasia Kuznetsova, Amulya Jayadev, Hiwot Amare, Sofia Valenciano, Nadia Meyer
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 8, Pp 1789-1805 (2024)
Abstract Introduction Respiratory syncytial virus (RSV) and influenza pose major disease burdens in older adults due to an aging immune system and comorbidities; seasonal overlap exists between these infections. In 2023, the RSV prefusion protein F3
Externí odkaz:
https://doaj.org/article/2564e83a5ebe461eaac4c6532a3a7d1b
Autor:
Ilona Trautmannsberger, Barbara Plagg, Ina Adamek, Silke Mader, Daniele de Luca, Susanna Esposito, Sven Arne Silfverdal, Luc J. I. Zimmermann, Christina Tischer, the ResQ Family study group
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1531-1573 (2024)
Abstract Introduction Since the majority of hospitalisations due to RSV occur in young children, the illness profoundly influences the entire family. However, comprehensive evidence regarding its overall effects remains limited. The ResQ Family study
Externí odkaz:
https://doaj.org/article/9ba0466db57c4c8891a1b2a24ba74dab
Autor:
Javier Álvarez Aldean, Irene Rivero Calle, Rosa Rodríguez Fernández, Susana Aceituno Mata, Alba Bellmunt, Miriam Prades, Amy W. Law, Alejandra López-Ibáñez de Aldecoa, Cristina Méndez, María L. García Somoza, Javier Soto, Virginia Lozano
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 6, Pp 1315-1331 (2024)
Abstract Introduction Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRI) in children under one year of age. In high-income countries, RSV infections cause a significant overload of care every winter, i
Externí odkaz:
https://doaj.org/article/5219b396441c40ccac9837368236f874
Autor:
Valerie Williams, Carla DeMuro Romano, Lyn Finelli, Shanshan Qin, Todd L. Saretsky, Jia Ma, Sandy Lewis, Matthew Phillips, Richard H. Osborne, Josephine M. Norquist
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background Despite a number of respiratory syncytial virus (RSV) vaccine candidates being tested in clinical trials, disease-specific, self-reported instruments assessing symptom severity of RSV infection from the perspective of adult patien
Externí odkaz:
https://doaj.org/article/529fe222041240c385c399d2f0052e83
Autor:
Min-Ju Kim, Ki Back Chu, Su-Hwa Lee, Jie Mao, Gi-Deok Eom, Keon-Woong Yoon, Eun-Kyung Moon, Fu-Shi Quan
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Excessive pulmonary inflammation is the hallmark of respiratory syncytial virus (RSV) infection hindering efficacious RSV vaccine development. Yet, the vast majority of the experimental RSV vaccine studies use laboratory-adapted RSV strains
Externí odkaz:
https://doaj.org/article/800b3df03e2641c4935a66ae5d3992ea
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new preventive monoclonal antibody (MAb), nirsevimab, has
Externí odkaz:
https://doaj.org/article/2993496d2a00460eaa301efa69062212
Autor:
Ana Vieira Antão, Friederike Oltmanns, Anna Schmidt, Vera Viherlehto, Pascal Irrgang, Marie-Anne Rameix-Welti, Wibke Bayer, Dennis Lapuente, Matthias Tenbusch
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Influenza A Virus (IAV) and Respiratory Syncytial Virus (RSV) are both responsible for millions of severe respiratory tract infections every year worldwide. Effective vaccines able to prevent transmission and severe disease, are important measures to
Externí odkaz:
https://doaj.org/article/9564d989b533458a88eedb4bdbf7cc63
Autor:
Giovanni Vitali Rosati
Publikováno v:
Global Pediatrics, Vol 8, Iss , Pp 100132- (2024)
After COVID-19, there was a resurgence of viral and bacterial diseases globally. Data from January 2023 indicates a shift in infectious disease patterns, with influenza, RSV, SARS-CoV-2, and other viruses prevalent, leading to a termed “polyendemia
Externí odkaz:
https://doaj.org/article/ce295b858658492aac098cc38f4eb56b
Publikováno v:
F1000Research, Vol 13 (2024)
Background Respiratory syncytial virus (RSV) is one of the most significant respiratory pathogens that causes acute lower respiratory tract infections (LRTI) early in life. Most children have a history of RSV infection within 24 months of age, and re
Externí odkaz:
https://doaj.org/article/0cde56f77c434c129e9d188adb4899b3